A trio of recent studies conducted at the University of Alberta has unveiled a concerning connection between Type 2 diabetes and undetected cardiovascular disease.
These studies have highlighted the role of two protein biomarkers—high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide—in indicating heart damage, even in individuals who have not experienced symptoms or a known history of cardiovascular disease.
The research, published in the Journal of the American Heart Association, suggests that these biomarkers may serve as early warning signs of structural and functional heart changes, elevating the risk of future heart failure, coronary heart disease, or even death.
Identifying High-Risk Individuals
The study, led by Dr. Elizabeth Selvin, a professor of epidemiology at Johns Hopkins Bloomberg School of Public Health, aimed to shed light on the prevalence of undetected cardiovascular disease among adults with Type 2 diabetes.
Type 2 diabetes, a widespread metabolic disorder, has long been associated with an increased risk of heart-related complications.
However, this research delves into a subgroup of individuals who may be at heightened risk, even without a prior history of cardiovascular issues.
The Scope of the Study
The research analyzed data from over 10,300 adults who participated in the U.S. National Health and Nutrition Examination Survey between 1999 and 2004.
All participants reported no previous history of cardiovascular disease when they enrolled in the study.
The scientists assessed whether elevated levels of the two cardiac protein biomarkers could predict previously unrecognized cardiovascular disease and its associated risks among both Type 2 diabetes patients and those without diabetes.
Key Findings
The study yielded several crucial findings:
High Prevalence in Type 2 Diabetes: Approximately 33.4% of adults with Type 2 diabetes displayed elevated levels of the two protein biomarkers, indicating undetected cardiovascular disease. In contrast, only 16.1% of individuals without diabetes exhibited such markers.
Increased Risk for Adverse Outcomes: Among adults with Type 2 diabetes, elevated levels of troponin and N-terminal pro-B-type natriuretic peptide were linked to a significantly higher risk of all-cause death (77% and 78% increased risk, respectively) and cardiovascular death (54% and more than double the increased risk, respectively).
These elevated risks remained even after accounting for other cardiovascular risk factors.
Duration of Diabetes and Control Matters: Notably, individuals who had Type 2 diabetes for a longer duration and those with poorly controlled blood sugar levels were more likely to have elevated troponin levels.
Implications and Future Directions
While cholesterol has historically been the primary focus for reducing cardiovascular risk in Type 2 diabetes patients, this research suggests that the disease may directly impact the heart in ways unrelated to cholesterol levels.
Therefore, traditional cholesterol-lowering medications may not be sufficient to prevent cardiac damage.
Dr. Selvin stresses the need for additional non-statin therapies to mitigate cardiovascular disease risk in this population.
The study also highlights the potential utility of routinely measuring these cardiac biomarkers alongside traditional risk factors.
Identifying high-risk individuals early on could enable healthcare providers to implement preventative strategies and interventions tailored to each patient’s unique needs.
It is important to note that the research is among the first of its kind and provides insights into the broader population.
However, further investigation is needed to determine whether routine biomarker measurements can effectively reduce cardiovascular complications in individuals with Type 2 diabetes.
The findings underscore the critical importance of addressing the complex relationship between Type 2 diabetes and cardiovascular health.
In 2020 alone, diabetes was attributed to over 100,000 deaths in the United States and an estimated 1.64 million deaths worldwide, according to the American Heart Association.
This research paves the way for a more nuanced approach to managing the cardiovascular risk associated with Type 2 diabetes, ultimately improving the health outcomes of millions of individuals worldwide.
If you care about diabetes, please read studies about new way to achieve type 2 diabetes remission, and one avocado a day keeps diabetes at bay.
For more information about diabetes, please see recent studies about 5 dangerous signs you have diabetes-related eye disease, and results showing why pomegranate is super fruit for people with diabetes.
The research findings can be found in the Journal of the American Heart Association.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
